What is the most recent earnings date for ANAB stock?
ANAPTYSBIO INC (ANAB) last reported earnings on 3/3/2026.
ANAPTYSBIO INC (ANAB) Earnings History & Surprises
NASDAQ:ANAB • US0327241065
Current stock price
51.82 USD
+0.87 (+1.71%)
At close:
51.82 USD
0 (0%)
After Hours:
ANAB Earnings overview
Past quarterly earnings results for ANAPTYSBIO INC (ANAB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.96
- Revenue Estimate
- 29.123M
Last Reported
Most Recent- Release Date
- Mar 3, 2026
- Period
- Q4 / 2025
- EPS Reported
- $1.58
- EPS Surprise
- 65.04%
- Revenue Surprise
- 15.29%
Beat Rate
Last 8 Quarters 75%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.58 | 0.96 | 65.04% | 319.44% | 108.249M | 93.892M | 15.29% | 151.08% |
| Q3 2025 | 0.52 | -1.47 | 135.42% | 145.61% | 76.32M | 16.128M | 373.21% | 154.26% |
| Q2 2025 | -1.34 | -1.57 | 14.78% | 21.64% | 22.263M | 11.783M | 88.94% | 102.93% |
| Q1 2025 | -1.28 | -1.28 | -0.12% | 21.95% | 27.771M | 15.579M | 78.26% | 286.84% |
| Q4 2024 | -0.72 | -1.65 | 56.40% | 54.72% | 43.113M | 7.923M | 444.15% | 378.77% |
| Q3 2024 | -1.14 | -1.68 | 32.14% | 19.15% | 30.017M | 7.01M | 328.20% | 804.67% |
| Q2 2024 | -1.71 | -1.01 | -69.51% | -14.00% | 10.971M | 24.787M | -55.74% | 217.08% |
| Q1 2024 | -1.64 | -1.60 | -2.69% | -3.80% | 7.179M | 4.047M | 77.39% | 422.49% |
| Q4 2023 | -1.59 | -1.63 | 2.65% | -70.97% | 9.005M | 2.273M | 296.17% | 32.23% |
| Q3 2023 | -1.41 | -1.83 | 22.95% | -19.49% | 3.318M | 2.481M | 33.74% | 157.21% |
| Q2 2023 | -1.50 | -1.73 | 13.36% | -30.43% | 3.46M | 3.388M | 2.13% | 183.61% |
| Q1 2023 | -1.58 | -1.07 | -47.81% | -20.61% | 1.374M | 3.647M | -62.33% | 41.65% |
| Q4 2022 | -0.93 | -0.98 | 4.74% | 17.70% | 6.81M | 6.967M | -2.25% | 574.26% |
| Q3 2022 | -1.18 | -0.74 | -59.94% | -391.67% | 1.29M | 10.55M | -87.77% | -93.82% |
| Q2 2022 | -1.15 | -1.04 | -10.35% | -5,650.00% | 1.22M | 4.808M | -74.63% | -95.94% |
| Q1 2022 | -1.31 | -1.01 | -29.08% | -98.48% | 970K | 5.155M | -81.18% | -91.38% |
| Q4 2021 | -1.13 | 2.62 | -143.06% | -194.17% | 1.01M | 113.1M | -99.11% | -98.32% |
| Q3 2021 | -0.24 | -0.93 | 74.10% | 72.41% | 20.89M | 6.808M | 206.84% | - |
| Q2 2021 | -0.02 | -0.11 | 81.70% | 97.47% | 30.03M | 29.459M | 1.94% | - |
| Q1 2021 | -0.66 | -0.70 | 5.95% | -120.00% | 11.25M | 9.577M | 17.47% | -25.00% |
| Q4 2020 | 1.20 | 1.42 | -15.48% | - | 60M | 65.28M | -8.09% | - |
| Q3 2020 | -0.87 | -0.74 | -18.25% | - | 1.7M | -100.00% | - | |
| Q2 2020 | -0.79 | -0.76 | -3.29% | - | 2.368M | -100.00% | - | |
| Q1 2020 | -0.30 | -0.64 | 53.31% | - | 15M | 6.375M | 135.29% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
53.78%
Max EPS beat (4)
135.42%
Min EPS beat (4)
-0.12%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
138.93%
Max Revenue beat (4)
373.21%
Min Revenue beat (4)
15.29%
Analysis
In the last 4 quarters, ANAB has beaten EPS estimates in 3 out of 4 releases
ANAB has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ANAB has beaten the EPS estimates by 53.8% on average.
In the last 4 quarters, ANAB has beaten the revenue estimates by 138.9% on average.
Related analysis
ANAPTYSBIO INC / ANAB Earnings FAQ
Can you provide information on whether ANAPTYSBIO INC beat earnings estimates in the last quarter?
ANAPTYSBIO INC (ANAB) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does ANAPTYSBIO INC (ANAB) beat earnings estimates?
In the last 4 quarters, ANAPTYSBIO INC (ANAB) has beaten EPS estimates in 3 out of 4 releases.